Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. | Front Immunol | 2022 | 36505470 | PubTator, text mining | PubMed |
| Therapeutic Antibodies in Cancer Treatment in the UK. | Int J Mol Sci | 2022 | 36498915 | PubTator, text mining | PubMed |
| Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia. | J Transl Med | 2022 | 36494694 | PubTator, text mining | PubMed |
| The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma. | J Oncol | 2022 | 36483984 | PubTator, text mining | PubMed |
| Commercial DURAClone panels for extending the repertoire of multicolour immunophenotypic panels in an academic flow cytometry laboratory in South Africa. | Afr J Lab Med | 2022 | 36483322 | PubTator, text mining | PubMed |
| Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes. | J Transl Med | 2022 | 36474294 | PubTator, text mining | PubMed |
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial. | EJHaem | 2022 | 36467814 | PubTator, text mining | PubMed |
| Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma. | Front Oncol | 2022 | 36465410 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review. | Front Oncol | 2022 | 36465385 | PubTator, text mining | PubMed |
| Naïve B cells with low differentiation improve the immune reconstitution of HIV-infected patients. | iScience | 2022 | 36465118 | PubTator, text mining | PubMed |
| The Immunomodulatory Functions of BTK Inhibition in the Central Nervous System. | J Inflamm Res | 2022 | 36452053 | PubTator, text mining | PubMed |
| Single Cell RNA-Sequence Analyses Reveal Uniquely Expressed Genes and Heterogeneous Immune Cell Involvement in the Rat Model of Intervertebral Disc Degeneration. | Appl Sci (Basel) | 2022 | 36451894 | PubTator, text mining | PubMed |
| Autoantibodies as biomarkers for breast cancer diagnosis and prognosis. | Front Immunol | 2022 | 36451832 | PubTator, text mining | PubMed |
| Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma. | Medicine (Baltimore) | 2022 | 36451444 | PubTator, text mining | PubMed |
| Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models. | Sci Rep | 2022 | 36443381 | PubTator, text mining | PubMed |
| Genetic resilience in chickens against bacterial, viral and protozoal pathogens. | Front Vet Sci | 2022 | 36439341 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| Bioinformatics analysis of gene expression profile and functional analysis in periodontitis and Parkinson's disease. | Front Aging Neurosci | 2022 | 36437997 | PubTator, text mining | PubMed |
| Genomic disparities between cancers in adolescent and young adults and in older adults. | Nat Commun | 2022 | 36433963 | PubTator, text mining | PubMed |
| Molecular Characterization of a B Cell Adaptor for Phosphoinositide 3-Kinase Homolog in Lamprey (Lampetra japonica) and Its Function in the Immune Response. | Int J Mol Sci | 2022 | 36430927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=49